CompletedNot applicableNCT00000636
Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
Studying Tuberculosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- Gordin F, LPC
- Intervention
- Isoniazid(drug)
- Enrollment
- 2000 enrolled
- Eligibility
- 13 years · All sexes
- Timeline
- 1997
Study locations (25)
- Community Consortium / UCSF, San Francisco, California, United States
- Denver CPCRA / Denver Public Hlth, Denver, Colorado, United States
- Hill Health Corp, New Haven, Connecticut, United States
- Wilmington Hosp / Med Ctr of Delaware, Wilmington, Delaware, United States
- Veterans Administration Med Ctr / Regional AIDS Program, Washington D.C., District of Columbia, United States
- AIDS Research Consortium of Atlanta, Atlanta, Georgia, United States
- Chicago Dept of Health / Speciality STD Clinic, Chicago, Illinois, United States
- AIDS Research Alliance - Chicago, Chicago, Illinois, United States
- Louisiana Comm AIDS Rsch Prog / Tulane Univ Med, New Orleans, Louisiana, United States
- Johns Hopkins Univ / Brazil, Baltimore, Maryland, United States
- Johns Hopkins Univ / School of Hygiene & Public Health, Baltimore, Maryland, United States
- Boston Dept of Health and Hosps, Boston, Massachusetts, United States
- Comprehensive AIDS Alliance of Detroit, Detroit, Michigan, United States
- Henry Ford Hosp, Detroit, Michigan, United States
- Southern New Jersey AIDS Cln Trials / Dept of Med, Camden, New Jersey, United States
- +10 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00000636 on ClinicalTrials.govOther trials for Tuberculosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07164742Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)Johns Hopkins University
- RECRUITINGNCT0707721318F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis PatientsChildren's Hospital Medical Center, Cincinnati
- ENROLLING BY INVITATIONNANCT06984887Evaluation of New TB Diagnostic Tests (NATs) in PakistanMercy Corps Pakistan
- RECRUITINGNCT07018076Candidate Clinical Correlate of Prognostic Outcome for TB StudyUniversity of California, San Francisco
- RECRUITINGNANCT07271225Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and VomitingIndonesia University
- RECRUITINGNCT06585358DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary TuberculosisKarolinska Institutet
- RECRUITINGPHASE3NCT06497465Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB TreatmentJohns Hopkins University
- RECRUITINGNCT07178860Respiratory Health and Wellbeing Post Pulmonary TuberculosisLiverpool School of Tropical Medicine